<html>
<head>PUBMED IDs for EMSY</head>
<body bgcolor='#C5F0F2'><h1>EMSY</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14651845/'>EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.</a> December 4  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14651841/'>The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis.</a> December 4  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14760417/'>EMSY, a BRCA-2 partner in crime.</a> February 5  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15318925/'>EMSY links breast cancer gene 2 to the 'Royal Family'.</a> August 21  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15351094/'>Oncogenic pathways in hereditary and sporadic breast cancer.</a> September 8  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355907/'>Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355904/'>Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355899/'>Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355896/'>N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355895/'>A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355893/'>Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355892/'>HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15355890/'>Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15978617/'>Crystal structure of the ENT domain of human EMSY.</a> June 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16029503/'>Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.</a> July 21  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16145051/'>Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.</a> September 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16236351/'>Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.</a> October 21  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17477772/'>Evaluation of DNA extraction methods and real time PCR optimization on formalin-fixed paraffin-embedded tissues.</a> May 5  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18314909/'>Amplification of 11q13 in ovarian carcinoma.</a> March 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18376068/'>A gene-trap strategy identifies quiescence-induced genes in synchronized myoblasts.</a> April 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18393977/'>Genetic alterations of CCND1 and EMSY in breast cancers.</a> April 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18787380/'>Absence of allelic imbalance involving EMSY, CAPN5, and PAK1 genes in papillary thyroid carcinoma.</a> September 13  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19131338/'>Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation.</a> May 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19636701/'>Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.</a> August 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20349280/'>Expression of EMSY gene in sporadic ovarian cancer.</a> March 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20473280/'>Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.</a> October 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20978320/'>Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.</a> March 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20978319/'>VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin.</a> March 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20978318/'>Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type.</a> April 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21064104/'>Identification of an aggressive prostate cancer predisposing variant at 11q13.</a> July 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21327470/'>EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21735447/'>Functional characterization of EMSY gene amplification in human cancers.</a> October 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22315412/'>The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY.</a> May 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22527098/'>Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification.</a> January 25  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22527097/'>Comments on the use of a single or multiple probeset approach for microarray-based analyses of routine molecular markers in breast cancer.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23117821/'>Akt1, EMSY, BRCA2 and type I IFN signaling: a novel arm of the IFN response.</a> November 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23729402/'>Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer.</a> February 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24641409/'>Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas.</a> November 19  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25437005/'>A genomic instability score in discriminating nonequivalent outcomes of BRCA1/2 mutations and in predicting outcomes of ovarian cancer treated with platinum-based chemotherapy.</a> September 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25510665/'>EMSY promoted the growth and migration of ovarian cancer cells.</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26841866/'>Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.</a> August 16  2016<br></body></html>
